期刊文献+

人端粒酶RNA基因扩增和高危型HPV感染检测对宫颈癌及宫颈上皮内瘤变的预测意义 被引量:8

Prediction of Cervical Cancer and Cervical Intraepithelial Neoplasia by Amplification of Human Telomerase RNA Gene(hTERC) and Detection of High-risk Human Papillomavirus Infection
下载PDF
导出
摘要 目的:研究人端粒酶RNA基因(hTERC)扩增及高危型人乳头瘤病毒(HR-HPV)在宫颈癌和宫颈上皮内瘤变(CIN)脱落细胞的表达,以探讨其在早期宫颈病变和疾病发展的作用和临床意义。方法:分别采用荧光原位杂交技术(FISH)和第2代杂交捕获法(HCⅡ),检测26例宫颈良性病变/湿疣、27例CIN、41例浸润性宫颈癌(ICC)共94例患者的hTERC基因扩增杂交信号数及HR-HPV阳性感染,上述两种检测方法与宫颈病理组织学结果对照。结果:hTERC基因在ICC组阳性表达为85.37%,高于CINⅡ~Ⅲ组(15.83%)、CINⅠ组(7.14%)与良性病变组(6.67%,1/15),差异有高度统计学意义(P<0.01);HR-HPV阳性感染率在良性病变/湿疣、CINⅠ、CINⅡ~Ⅲ、ICC分别为46.15%,71.43%,38.46%和19.51%;hTERC基因FISH检测对宫颈上皮病变的阳性预测值(PPV)和特异度(Sp)分别为92.68%、88.46%,明显高于HR-HPV-HCⅡ检测(65.71%、53.85%),P<0.01;敏感度(Se)55.88%,阴性预测值(NPV)43.40%,亦高于后者(33.82%、23.73%),P<0.05。结论:hTERC基因FISH检测与HR-HPV-HCⅡ检测比较能更可靠地辨别宫颈病变的程度;检测hTERC基因扩增对判断早期宫颈病变进展风险可能有一定的预测意义,有望作为宫颈癌早期筛查、病情判断和评估预后的辅助指标之一。 Objective:To explore the amplification of Human Telomerase RNA gene( hTERC) and the expression of high-risk Human Papilomavirus (HR-HPV) in cervical shed cells from invasive cervical cancer(ICC) and cervical intraepithelial neoplasia(CIN),and to evaluate their effect and clinical significance in the early stage of cervical lesion and development of disease. Methods:Fluorescence in situ hybridization (FISH) and hybrid captureⅡ(HCⅡ) were used to detect the expression of hTERC gene and HR-HPV infection in 41 cases of ICC,27 cases of CIN and 26 cases of benign cervical lesion/condyloma,meanwhile,the results of these two methods were compared with the results of cervical histopathology. Results:There was significant difference in positive expression rate of hTERC gene in ICC (85.37%) compared with CINⅡ-Ⅲ (15.83%),CINⅠ(7.14%) and benign cervical lesion(6.67%) (P〈0.01). Positive infection rate of HR-HPV in benign cervical lesion/ condyloma,CINⅠ,CINⅡ-Ⅲ and ICC was 46.15%,71.43%,38.46% and 19.51% respectively. The positive predictive value( PPV) and specificities( Sp) of hTERC gene in cervical epithelial lesions by FISH was 92.68% and 88.46%,which was significantly higher than that by HR-HPV HCⅡ test (65.71% and 53.85%,P0.01). The Sensitivity ( Se ) and negative predictive value(NPV) of hTERC gene in cervical epithelial lesion by FISH was 55.88% and 43.40%,which was higher than that by HR-HPV HCⅡ test (Se 33.82%,,NPV 23.73%,P0.05).Conclusions:Detection of hTERC gene by FISH is more reliable to different the degree of cervical lesion than HR-HPV HCII. Detection of hTERC gene amplification may has some predictive significance in the judgment of the progressive risk of early cervical lesion,which may be used as a forecast index for early screening of cervical cancer,judging disease severity and evaluating prognosis.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2010年第11期842-845,I0001,共5页 Journal of Practical Obstetrics and Gynecology
基金 卫生部科研基金资助项目(WKJ2007-3-001)
关键词 HTERC基因 高危型HPV 荧光原位杂交 宫颈病变 宫颈癌 Human Telomerase (hTERC) gene High-risk Human Papillomavirus (HR-HPV) Fluorescence in situ hybridization (FISH) Cervical lesions Cervical cancer
  • 相关文献

参考文献10

二级参考文献45

  • 1陈道桢,耿金花,薛文群,张丽珊.染色体不稳定性及其与妇科肿瘤形成关系的研究进展[J].东南大学学报(医学版),2004,23(5):355-357. 被引量:9
  • 2郎景和.子宫颈病变防治的几个问题[J].世界医学杂志,2004,8(11):1-3. 被引量:84
  • 3吕卫国,谢幸.宫颈癌的筛查[J].中国实用妇科与产科杂志,2006,22(1):8-9. 被引量:95
  • 4岑坚敏,钱德英,王丁,曾仁海,林爱华,舒焰红,洪淡华,黄志宏.高危型人类乳头瘤病毒检测对不典型鳞状细胞分流监测的临床价值[J].中华妇幼临床医学杂志(电子版),2006,2(1):12-14. 被引量:21
  • 5耿晓星,马荣,朱镭,高庆玉.HPV和TCT检测对LEEP治疗CIN效果的监测意义[J].中国肿瘤临床,2006,33(11):608-610. 被引量:5
  • 6Heselmeyer-Haddad K, Janz V, Castle PE, et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia [ J ]. Am J of Pathol, 2003, 163 : 1406-1416
  • 7Umayahara K, Numa F, Suehiro Y, et al. Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression [ J ]. Genes Chromosomes Cancer,2002,33:98-102
  • 8Kloth JN, Oosting J, van Wezel T, et al. Combined arraycomparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer [ J ]. BMC Genomics, 2007,8 : 53-66
  • 9Olaharskil AJ, Sotelo R, Solorza-Luna G, et al. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis [ J ]. Carcinogenesis, 2006,27 : 337-343
  • 10Kersemaekers AM, van de Vijver M J, Kenter GG, et al. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix [ J ]. Genes Chromosomes Cancer, 1999,26 : 346 -354

共引文献76

同被引文献74

  • 1陈娇,刘小明,方爱儿.必兰临床使用护理配合体会[J].赣南医学院学报,2006,26(2):284-284. 被引量:2
  • 2许丹,张玉泉.HPV疫苗防治宫颈癌的研究进展[J].现代妇产科进展,2007,16(2):137-139. 被引量:9
  • 3CliffordGM,SmithJS,PlummerM,etal.Humanpapillomavirustypesininvasivecervicalcancerworldwide:ameta-analysis[J].BrJCancer,2003,88(1):63-73.
  • 4GopalkrishnaV,AggarwalN,MalhotraVL,etal.Chlamydiatracho-matisandhumanpapillomavirusinfectioninIndianwomenwithsexuallytransmitteddiseasesandcervicalprecancerousandcancer-ouslesions[J].ClinMicrobiolInfect,2007,6(2):88-93.
  • 5陈祥生,尹跃平,王千秋.性传播疾病的实验室诊断[M].北京:人民卫生出版社,2005:68-74.
  • 6Yang RY, Liu FT. Galectins in cell growth and apoptosis [ J ]. Cell Mol Life Sci, 2003, 60(2) : 267 -276.
  • 7Pace KE, Hahn HP, Pang M, et al. CD7 delivers a pro-poptotic sig- nal during galectin-I induced T cell death[J]. J Immunol, 2000, 165(5) : 2331 -2334.
  • 8Thijssen VL, Postel R, Brandwijk RJ, et al. Galectin-I is essential in tumor angiogenesis and is a target for antiangiogenesis therapy [ J 1. Proc Natl Acad Sci USA, 2006, 103 (43) : 15975 - 15980.
  • 9朱曦龄,梁莉,丁彦青.Galectin-1在大肠癌组织中的表达及其临床意义[J].南方医科大学学报,2007,27(9):1331-1334. 被引量:7
  • 10Yang RY, Liu FT. Galectins in cell growth and apoptosis [J]. Cell Mol Life Sci, 2003, 60(2): 267-276.

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部